Amerol, Daneen Aakifah T.
HRN: 22-05-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
CEFUROXIME 750MG (VIAL)
05/20/2025
05/27/2025
IV
350mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes